Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Cephalosporin Drugs Market Analysis & Trends 2015-2017 - 2018 Industry Forecast to 2027 - ResearchAndMarkets.com

Research and Markets
Posted on: 21 Feb 18

The "Global Cephalosporin Drugs Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The Global Cephalosporin Drugs Market is poised for grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include rising incidence of diseases, growing research & development activities and increasing healthcare awareness.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies for the existing players, new entrants and the future investors.

Key Topics Covered:

1 Market Outline

1.1 Research Methodology

1.2 Market Trends

1.3 Regulatory Factors

1.4 Product Analysis

1.5 Strategic Benchmarking

1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Raising incidence of diseases

3.1.2 Growing research & development activities

3.1.3 Increasing healthcare awareness

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

4 Cephalosporin Drugs Market, By Cable Type

4.1 Generics

4.2 Branded

5 Cephalosporin Drugs Market, By Route of Administration

5.1 Injectables

5.2 Oral

6 Cephalosporin Drugs Market, By Spectrum

6.1 Fifth Generation

6.2 Fourth Generation

6.3 Third Generation

6.4 Second Generation

6.5 First Generation

7 Cephalosporin Drugs Market, By Type of Treatment

7.1 First Line of Treatment

7.2 Second Line of Treatment

8 Cephalosporin Drugs Market, By Geography

9 Key Player Activities

9.1 Mergers & Acquisitions

9.2 Partnerships, Joint Venture's, Collaborations and Agreements

9.3 Product Launch & Expansions

9.4 Other Activities

10 Leading Companies

  • Abbott
  • Allergan
  • Aspen Pharmacare
  • Astellas
  • Basilea Pharmaceuticals
  • Baxter
  • Bristol-Myers Squibb
  • Glaxo SmithKline
  • Kyorin Pharmaceutical
  • Lupin Pharmaceuticals
  • Merck
  • Pfizer
  • Ranbaxy
  • Roche
  • Sandoz
  • Teva Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/3pxrvr/global?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180221005584/en/

Business Wire
www.businesswire.com

Last updated on: 21/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.